3-Rabies Vaccine
Shown to be effective against rabies for at least 1 year in ferrets and at least 3 years in dogs and cats after repeat dose.
Product Description
NOBIVAC® 3-RABIES provides protection to cats against Rabies
An effective 3 year vaccine to protect against rabies in cats and dogs. Also effective for 1 year in ferrets.
- Produced on an established cell line that has been extensively tested1
- A duration of immunity study demonstrated that a 1 mL dose met federal guidelines for protection of dogs and cats against virulent challenge administered 3 years after vaccination1
Indications:
This product has been shown to be effective for the vaccination of healthy dogs, cats and ferrets 12 weeks of age or older against rabies. Duration of immunity of at least 1 year has been demonstrated in ferrets, and at least 3 years in dogs and cats after repeat dose. For more information regarding efficacy and safety data, go to productdata.aphis.usda.gov.
EFFICACY & COMPARISONS
Rabies Challenge Studies
- Duration of immunity studies demonstrated that a 1 mL dose met federal guidelines for protection of dogs and cats against virulent challenge administered 3 years after vaccination and ferrets when challenged 1 year after vaccination.

NOBIVAC® 3-RABIES VACCINE IS A SAFE CHOICE
- Proven to be uniformly safe in experimental tests, with no significant adverse reactions in extensive clinical trials.1
ADMINISTRATION AND DOSAGE
- Subcutaneous 1 mL injection for cats
- Subcutaneous or intramuscular 1 mL injection for dogs
- Administer a single dose at 12 weeks of age or older in healthy cats and dogs; repeat dose should be administered 1 year later
- Subcutaneous 1 mL injection for ferrets, repeat dose should be administered 1 year later. Annual revaccination with 1 dose is recommended.
- Available in two presentations: 50 x 1 mL, and 5 x 10 mL vials
ALSO AVAILABLE IN OTHER FORMULATIONS
DISEASE INFORMATION
Professional Resources and Educational Materials
Keep your clinic and staff informed and aware of diseases and outbreaks.
View More Nobivac ResourcesReferences
Go To United States
Algeria
Argentina
Australia
Austria
Bahrain
Belgium (Dutch)
Brazil
Canada (English)
Chile
Colombia
Croatia
Czech Republic
Denmark
Ecuador
Egypt
Finland
France
Germany
Greece
Hungary
India
Indonesia
Iraq
Ireland
Israel
Italy
Japan
Jordan
Kuwait
Lebanon
Malaysia
Mexico
Morocco
Netherlands
New Zealand
Norway
Oman
Panama
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russian Federation
Saudi Arabia
South Africa
South Korea
Spain
Sweden
Switzerland (French)
Taiwan
Thailand
Tunisia
Turkey
Ukraine
United Arab Emirates
United Kingdom
Uruguay
Yemen
Global